Mercer Global Advisors’s Pulse Biosciences PLSE Stock Holding History

Mercer Global Advisors’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60.2K	Buy	+2,171	New	+$51.2K	﹤0.01%	4183

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Mercer Global Advisors's PLSE Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Pulse Biosciences (PLSE) in Q2 2026: 2,171 shares worth $60.2K. The stake represents ﹤0.01% of the portfolio and ranks #4183 among its holdings.

99 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

Mercer Global Advisors held 2,171 shares of Pulse Biosciences worth $60.2K as of Q2 2026.
Pulse Biosciences was a new Mercer Global Advisors position in Q2 2026.
Pulse Biosciences made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4183 holding.
99 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.